Safety and Efficacy of Bimatoprost Solution 0.03% Topical Application in Patients with Chemotherapy-Induced Eyelash Loss

    December 2013 in “ Journal of Investigative Dermatology Symposium Proceedings ”
    Gurpreet S. Ahluwalia
    Studysummary In this study, once-daily treatment with bimatoprost 0.03% solution significantly increased eyelash growth, thickness, and darkness in patients with chemotherapy-induced eyelash loss compared to placebo, and was well tolerated over one year.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jidsponline.org →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Pathobiology of Chemotherapy-Induced Hair Loss The Lancet Oncology · 2013
    2. Chemotherapy-Induced Alopecia: Emotional Distress and Mitigation Strategies Seminars in Cutaneous Medicine and Surgery · 2009
    3. Skin Toxicity of Anti-Cancer Therapy Journal der Deutschen Dermatologischen Gesellschaft · 2008

    Related research 9

    1. Baricitinib Results in Eyebrow and Eyelash Growth in Patients With Alopecia Areata Who Do Not Achieve 20% or Less Scalp Hair Loss Journal of The American Academy of Dermatology · 2022
    2. Bimatoprost for the Treatment of Eyelash, Eyebrow, and Scalp Alopecia Expert Opinion on Investigational Drugs · 2017
    3. Bimatoprost Solution 0.03% Topical Application to the Eyelid Margin for the Treatment of Eyelash Hypotrichosis British Journal of Dermatology · 2016
    4. Long-Term Safety and Efficacy of Bimatoprost Solution 0.03% Application to the Eyelid Margin for the Treatment of Idiopathic and Chemotherapy-Induced Eyelash Hypotrichosis: A Randomized Controlled Trial British journal of dermatology/British journal of dermatology, Supplement · 2014
    5. The Prostamide-Related Glaucoma Therapy, Bimatoprost, Offers a Novel Approach for Treating Scalp Alopecias The FASEB Journal · 2012
    6. Long-Term Safety and Efficacy of Latisse (Bimatoprost 0.03% Solution) for Treatment of Eyelash Hypotrichosis in Subjects with Chemotherapy-Induced and Idiopathic Hypotrichosis Journal of The American Academy of Dermatology · 2012
    7. Topical Bimatoprost for the Treatment of Eyebrow Hypotrichosis PubMed · 2012
    8. Bimatoprost in the Treatment of Eyelash Hypotrichosis PubMed Central · 2010
    9. Bimatoprost in the Treatment of Eyelash Hypotrichosis Clinical ophthalmology · 2010